GlaxoSmithKline Pharmaceuticals Limited Stock price NSE India S.E.
Equities
GLAXO
INE159A01016
Pharmaceuticals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,947 INR | +3.55% | -2.00% | +2.55% |
Feb. 29 | Cynata Therapeutics Names Chief Business Officer; Shares Plunge 14% | MT |
Feb. 28 | Glaxosmithkline Pharmaceuticals Limited Appoints Aparajita Mukherjee Rajput, Technology Lead | CI |
Sales 2024 * | 33.65B 404M | Sales 2025 * | 36.49B 438M | Capitalization | 329B 3.95B |
---|---|---|---|---|---|
Net income 2024 * | 6.06B 72.77M | Net income 2025 * | 7.68B 92.15M | EV / Sales 2024 * | 9.78 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 9.02 x |
P/E ratio 2024 * |
48.3
x | P/E ratio 2025 * |
42.9
x | Employees | 3,680 |
Yield 2024 * |
1.56% | Yield 2025 * |
1.62% | Free-Float | 24.42% |
Latest transcript on GlaxoSmithKline Pharmaceuticals Limited
1 day | +3.55% | ||
1 week | -2.00% | ||
Current month | -10.45% | ||
1 month | -9.63% | ||
3 months | +5.25% | ||
6 months | +28.73% | ||
Current year | +2.55% |
Managers | Title | Age | Since |
---|---|---|---|
Bhushan Akshikar
CEO | Chief Executive Officer | 54 | 22-11-30 |
Juby Chandy
DFI | Director of Finance/CFO | - | 22-03-31 |
Simrat Sohal
CMP | Compliance Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Renu Sud Karnad
CHM | Chairman | 70 | 19-03-31 |
Manu Anand
BRD | Director/Board Member | 64 | 22-05-15 |
Director/Board Member | 74 | 15-03-29 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 1,947 | +3.55% | 120,032 |
24-03-27 | 1,880 | -2.17% | 250,305 |
24-03-26 | 1,922 | -2.12% | 133,017 |
24-03-22 | 1,963 | -1.17% | 267,395 |
24-03-21 | 1,986 | -0.64% | 142,721 |
Delayed Quote NSE India S.E., March 28, 2024 at 08:01 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+33.46% | 701B | |
+26.24% | 570B | |
+0.93% | 381B | |
+21.03% | 334B | |
+17.51% | 322B | |
+2.95% | 212B | |
+0.74% | 209B | |
-6.05% | 205B | |
-3.61% | 157B |
- Stock
- Equities
- Stock GlaxoSmithKline Pharmaceuticals Limited
- Stock GlaxoSmithKline Pharmaceuticals Limited - NSE India S.E.